Literature DB >> 6204557

Leydig cell hyperplasia due to a testicular embryonal carcinoma producing human chorionic gonadotropin.

S L Asa, T A Bayley, K Kovacs, E Horvath.   

Abstract

Report of the case of a 21-year-old man who presented with gynecomastia and was found to have a testicular embryonal carcinoma producing human chorionic gonadotropin (HCG), associated with massive hyperplasia of Leydig cells. While the morphologic features of Leydig cell hyperplasia have been documented with excess endogenous luteinizing hormone (LH), as in Klinefelter's syndrome, and following administration of exogenous HCG, to our knowledge, this is the first description of the histologic and ultrastructural changes in Leydig cells associated with increased secretion of endogenous HCG. The Leydig cell stimulation which results from excess endogenous HCG is unusual in that it causes an elevation of estrogens which may be greater than the rise in androgens. It is concluded that embryonal cell carcinoma of the testis, producing HCG, may lead to Leydig cell hyperplasia with morphologic features similar to those seen in other conditions with such hyperplasia, and that there is no correlation between those morphologic features and testosterone production.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6204557     DOI: 10.1111/j.1439-0272.1984.tb00254.x

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  3 in total

1.  Hyperplasia and hypertrophy of Leydig cells associated with testicular germ cell tumours containing syncytiotrophoblastic giant cells.

Authors:  U U Zimmerli; C E Hedinger
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

2.  An autopsy case of primary mixed choriocarcinoma and mature teratoma located in the thymic region associated with elevated human chorionic gonadotropin levels and characteristic testicular changes.

Authors:  Takashi Yuri; Naoto Shimano; Yasuhiro Ohashi; Katsuaki Miki; Reiko Tsukamoto; Airo Tsubura
Journal:  Med Mol Morphol       Date:  2006-03       Impact factor: 2.070

3.  Protective effect of chorionic gonadotropin on DMBA-induced mammary carcinogenesis.

Authors:  I H Russo; M Koszalka; P A Gimotty; J Russo
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.